Molecular imaging strategies for drug discovery and development

被引:77
作者
Gross, Shimon
Piwnica-Worms, David [1 ]
机构
[1] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
关键词
D O I
10.1016/j.cbpa.2006.06.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Recent advances in non-invasive molecular imaging provide exciting opportunities for discovery, validation and development of novel therapeutics. As the arsenal of detection devices and strategies, injectable probes, genetically encoded reporters and animal models rapidly expands, molecular imaging is becoming indispensable for drug discovery and development. Not only do such strategies reduce the time, cost and workload associated with conventional destructive end-point assays, but they also enable spatial and temporal monitoring of in vivo gene expression, signaling pathways, biochemical reactions and targets as they relate to the pharmacokinetics and pharmacodynamics of novel drugs.
引用
收藏
页码:334 / 342
页数:9
相关论文
共 44 条
[1]
In vivo molecular-genetic imaging: multi-modality nuclear and optical combinations [J].
Blasberg, RG .
NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (08) :879-888
[2]
Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis [J].
Bullok, K ;
Piwnica-Worms, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (17) :5404-5407
[3]
In vivo imaging of NF-κB activity [J].
Carlsen, H ;
Moskaug, JO ;
Fromm, SH ;
Blomhoff, R .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1441-1446
[4]
In vivo imaging of transcriptionally active estrogen receptors [J].
Ciana, P ;
Raviscioni, M ;
Mussi, P ;
Vegeto, E ;
Que, I ;
Parker, MG ;
Lowik, C ;
Maggi, A .
NATURE MEDICINE, 2003, 9 (01) :82-86
[5]
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model [J].
Cirrito, JR ;
Deane, R ;
Fagan, AM ;
Spinner, ML ;
Parsadanian, M ;
Finn, MB ;
Jiang, H ;
Prior, JL ;
Sagare, A ;
Bales, KR ;
Paul, SM ;
Zlokovic, BV ;
Piwnica-Worms, D ;
Holtzman, DM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3285-3290
[6]
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development [J].
Cullinane, C ;
Dorow, DS ;
Kansara, M ;
Conus, N ;
Binns, D ;
Hicks, RJ ;
Ashman, LK ;
McArthur, GA ;
Thomas, DM .
CANCER RESEARCH, 2005, 65 (21) :9633-9636
[7]
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[8]
Real-time imaging of ligand-induced IKK activation in intact cells and in living mice [J].
Gross, S ;
Piwnica-Worms, D .
NATURE METHODS, 2005, 2 (08) :607-614
[9]
Spying on cancer: Molecular imaging in vivo with genetically encoded reporters [J].
Gross, S ;
Piwnica-Worms, D .
CANCER CELL, 2005, 7 (01) :5-15
[10]
Extracellular replication of Listeria monocytogenes in the murine gall bladder [J].
Hardy, J ;
Francis, KP ;
DeBoer, M ;
Chu, P ;
Gibbs, K ;
Contag, CH .
SCIENCE, 2004, 303 (5659) :851-853